Sensitivity analysis for evaluating principal surrogate endpoints relaxing the equal early clinical risk assumption

DOI10.1214/21-AOAS1566zbMath1498.62222WikidataQ114599225 ScholiaQ114599225MaRDI QIDQ2170431

Yingying Zhuang, Ying Huang, Peter B. Gilbert

Publication date: 5 September 2022

Published in: The Annals of Applied Statistics (Search for Journal in Brave)

zbMATH Keywords

sensitivity analysiscausal inferenceprincipal stratificationestimated maximum likelihoodprincipal surrogatevaccine efficacy curve

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)

Cites Work

• Unnamed Item
• The evaluation of surrogate endpoints.
• Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine Trials
• Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine Trials
• Principal Stratification in Causal Inference
• Sensitivity Analysis for the Assessment of Causal Vaccine Effects on Viral Load in HIV Vaccine Trials
• Evaluating principal surrogate markers in vaccine trials in the presence of multiphase sampling
• Evaluating Candidate Principal Surrogate Endpoints
• Related Causal Frameworks for Surrogate Outcomes
• Sensitivity Analysis for Incomplete Contingency Tables: The Slovenian Plebiscite Case
• The validation of surrogate endpoints in meta-analyses of randomized experiments
• Augmented Designs to Assess Immune Response in Vaccine Trials
• Sensitivity Analyses Comparing Outcomes Only Existing in a Subset Selected Post‐Randomization, Conditional on Covariates, with Application to HIV Vaccine Trials
• A Generalization of Sampling Without Replacement From a Finite Universe

This page was built for publication: Sensitivity analysis for evaluating principal surrogate endpoints relaxing the equal early clinical risk assumption